Dilated cardiomyopathy may develop in patients with Aspergillus infection  by Yano, Shuichi
lable at ScienceDirect
Respiratory Medicine CME 3 (2010) 220–222Contents lists avaiRespiratory Medicine CME
journal homepage: www.elsevier .com/locate/rmedcCase Report
Dilated cardiomyopathy may develop in patients with Aspergillus infection
Shuichi Yano*, National Hospital Organization Matsue Medical Center
National Hospital Organization Matsue Medical Center, Pulmonary Medicine, Matsue, Japana r t i c l e i n f o
Article history:
Received 11 November 2009
Accepted 23 November 2009
Keywords:
Dilated cardiomyopathy (DCM)
Aspergillus terreus infection
Chronic necrotizing pulmonary aspergillosis
(CNPA)* Corresponding author. Tel.: þ81 852 21 6131.
E-mail address: yano@matsue.hosp.go.jp (S. Yano)
1755-0017/$36.00  2010 Elsevier Ltd. All rights rese
doi:10.1016/j.rmedc.2009.11.004a b s t r a c t
Dilated cardiomyopathy (DCM) is a syndrome characterized by cardiac enlargement and impaired
systolic function of one or both ventricles. Aspergillus has been reported to cause endocarditis,
myocarditis, pericarditis, mediastinitis, septic thrombophlebitis, and infections of aortic grafts. However,
to our knowledge, this is the ﬁrst case of DCM that might have resulted from Aspergillus terreus infection.
Physicians should be aware that DCM may develop in aspergillus infection.
 2010 Elsevier Ltd. All rights reserved.1. Case report
A 74-year-old man with progressive dyspnea presented at our
hospital on 5 September, 2006. He was referred by a local doctor for
further examination of abnormal shadow on chest imaging study.
Therewas no history of allergy, previousmajor illness, or risk factors
for immunodeﬁciency. He had worked in a metal factory for twenty
years and had a smoking history of 50 pack-year. The white cell
count was 10,200 per cubicmillimeter, with 72 percent neutrophils,
13 percent lymphocytes, 13 percent monocytes, and 2 percent
eosinophils. Serum C-reactive protein showed an elevation to
12.16 mg/dl. The values for liver and renal functions were normal
and serum fasting glucose level was normal. Serum CEA and CYFRA
were normal. Serum b-D glucan increased to 41.0 pg/ml. Serum
Aspergillus antigenwas negative, and the antigenwas negative in all
clinical course. Plain chest radiograph demonstrated hyperlucent
and ﬁbrous lung with right lung mass (Fig. 1(a)). Chest computed
tomography showed bilateral bullous lung with ﬁbrosis, and the
right B6masswith crescent sign (Fig.1(b)). Echocardiogram showed
only mild left ventricular hypertrophy. Left ventricular ejection
fraction slightly decreased to 48.5% and the pressure gradient from
tricuspid regurgitationwas 24.9 mmHg (Table 1). Aspergillus terreus
was detected in the sputum and bronchial washing ﬂuid by ﬁber-
optic bronchoscope. We diagnosed chronic necrotizing pulmonary
aspergillosis (CNPA) due to A. terreus infection occurring in
pulmonary ﬁbrosis and we started oral voriconazole of 200 mg per
day in our outpatient clinic from 7 September. Serum C-reactive
protein decreased 5.76 mg/dl on 20 October..
rved.On 28 December, he complained of severe dyspnea and arterial
blood gas analysis showed severe hypoxemia of 59.5 mmHg with
nasal prongs at 4 L/min. Hewas admitted for further examination of
dyspnea. On admission, the white cell count was 9600 per cubic
millimeter, with 91 percent neutrophils, 5 percent lymphocytes,
4 percent monocytes. Serum C-reactive protein showed an eleva-
tion to 13.18 mg/dl. Serum creatinine kinase was normal at 90 IU/l.
Serum b-D glucan increased to 43.8 pg/ml (Table 1). Plain chest
radiograph demonstrated enlargement of the right B6 mass with
cardiomegaly and right interlobar pleural effusion (Fig. 2(a)). Chest
computed tomography showed right B6 mass enlargement and
a new inﬁltration in the right middle lobe (Fig. 2(b)). The temper-
ature was 37.1 C. We diagnosed right middle lobe pneumonia
accompanied by congestive heart failure. Intravenous ciproﬂoxacin
and micafungin with oral voriconazole were administered from
28 December. As recovery of respiratory failure was late, we added
intravenous furosemide and sivelestat with pulse therapy of
methylprednisolone. He recovered from respiratory failure on
17 January 2007. Serum b-D glucan decreased to 29.8 pg/ml.
However, serum brain natriuretic peptide (BNP) was high at
538 pg/ml (Table 1). Echocardiogram showed diffuse hypokinesis of
the left ventricle and the left ventricular ejection fraction was
markedly decreased to 29.0% and these ﬁndings were compatible
with DCM. The pressure gradient from tricuspid regurgitation was
30.7 mmHg. As he did not have any complaints, he was discharged
on oxygen therapy on 23 February.
Thereafter, his clinical condition gradually progressed and the
patient was readmitted to our hospital a total of four times.
Although the values of serum b-D glucan ﬂuctuated within a rela-
tively small range, the values of BNP showed constantly increasing
levels and changed markedly with the state of cardiac failure.
The pressure gradient from tricuspid regurgitation changed from
Fig. 1. (a) Plain chest radiograph demonstrated hyperlucent and ﬁbrous lung with right lung ﬁeld mass. (b) Chest computed tomography showed bilateral bullous lung with ﬁbrosis,
and the right B6 mass with crescent sign.
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13.7 to 25.0% (Table 1). Coronary arteriogram (CAG) and endo-
myocardial biopsy of the right ventricle were performed on
29 August. CAG showed intact coronary arteries and the specimen
of right ventricle showed moderate myocardial hypertrophy with
25 mm width and many myocytes had degenerated to fat tissue.
There were no ﬁndings indicating direct invasion of A. terreus. We
deﬁnitely diagnosed DCM.
On 16 November, he was brought to our hospital in a coma by
ambulance. The white cell count was 52,000. Serum C-reactive
protein showed an elevation to 39.51 mg/dl. Serum creatinine
increased to 3.31 mg/dl and serum creatinine kinase increased
to1748 IU/l. Serum b-D glucan was 69.0 pg/ml. Serum BNP was
661 pg/ml (Table 1). Methicilin sensitive Staphylococcus aureuswas
detected from sputum. Although biapenem and micafungin were
administered, he did not recover. Three days after the admission, he
suddenly died probably due to ventricular ﬁbrillation. Autopsy did
not permitted.
2. Discussion
DCM is a syndrome characterized by cardiac enlargement and
impaired systolic function of one or both ventricles. More than half
of all patients with a clinical picture of DCM have no identiﬁable
etiology apparent despite rigorous evaluation and are therefore
considered to have idiopathic DCM.1,2 It is likely that this condition
represents a common expression of myocardial damage that has
been produced by a variety of yet to be identiﬁed myocardial
insults. Although the cause or causes remain unclear, interest has
centered on three possible basic mechanisms of damage1: familial
and genetic factors,2 viral myocarditis and other cytotoxic insults,
and3 immunological abnormalities. This patient had no apparent
familial linkage to DCM. The reported frequency of evidence of an
inﬂammatory inﬁltrate in DCM varies widely and undoubtedly
depends on the selection of patients and criteria used for diagnosis;Table 1
The changes of serum b-D glucan, BNP and left ventricular EF.
5 Sep. ’06 28 Dec. ’07 17 Jan. ’07 6 Apr. ’07 7 May ’07
b-D glucan (pg/ml) 41.0 43.8 29.8 48.4 59.6
BNP (pg/ml) 538 1770 484
CRP (mg/dl) 12.16 13.18 9.11 12.32 8.84
EF (%) 48.5 29.0 21.2
PG (mmHg) 24.9 30.7 46.3
BNP: brain natriuretic peptide, CRP: C-reactive protein, EF: ejection fraction of left ventrusing rigorous criteria, only about 15 percent (or less) of patients
with DCM show evidence of myocarditis on biopsy.3 Therefore,
we could not completely deny sequela of viral myocarditis by
endomyocardial biopsy; at least, endomyocardial biopsy in this
case did not demonstrate evidence of inﬂammatory myocarditis or
direct A. terreus invasion. Abnormalities of both humoral and
cellular immunity have been found in patients with DCM,4,5
although the ﬁndings have not been completely reproducible.1
Aspergillus has been reported to cause endocarditis, myocarditis,
pericarditis, mediastinitis, septic thrombophlebitis, and infections
of aortic grafts.6–10 Most cases occur in solid organ transplant
recipients, although the infection has been reported even in
immunocompetent patients.11 In immunocompromised patients,
myocarditis occurs as a consequence of a number of disseminated
infections. Overt myocarditis is common in disseminated toxo-
plasmosis, and systemic aspergillosis and candidiasis may also
involve the heart.3,12–17 However, this patient had no immunolog-
ical defects and did not demonstrate disseminated aspergillus only
CNPA due to A. terreus.
CNPA is an indolent form of invasive aspergillosis,18 or ‘‘semi-
invasive’’ pulmonary aspergillosis.19 This infection occurs in mildly
immunocompromised host (e.g., diabetes mellitus, low dosage
glucococorticoids) and often progresses slowly, usually over
a period of several months.20,21
Fungal-mediated host cell damage is an important component
of fungal virulence and is assumed to facilitate the invasion of host
tissues by disrupting host cell membranes, resulting in membrane
dysfunction and eventual cell death.21–23 Phospholipids and
proteins represent the major chemical constituents of the host cell
envelope. Therefore, enzymes such as phospholipase and
proteinase capable of hydrolyzing these proteins are likely to be
involved in the host cell-membrane disruption processes. Many
fungal pathogens secrete such extracellular proteins, which target
the protein or lipid component of host membranes. Thus, secretory
proteins have ﬁgured prominently among the list of factors28 May ’07 31 July ’07 8 Aug. ’07 11 Oct. ’07 22 Oct. ’07 16 Nov. ’07
61.8 38.7 41.9 39.8 69.0
1890 540 2080 1470 3730 661
18.88 11.24 4.56 13.3 39.52
21.9 25.0 13.7 18.8
46.8 38.6 43.0 30.8
icle, PG: pressure gradient by tricuspid regurgitation.
Fig. 2. (a) Plain chest radiograph demonstrated enlargement of the right B6 mass with cardiomegaly and right interlobar pleural effusion. (b) Chest computed tomography showed
the B6 mass enlargement and a new right middle lobe inﬁltration.
S. Yano et al. / Respiratory Medicine CME 3 (2010) 220–222222responsible for fungal virulence. These fungal secretory proteins
have been categorized into two main groups; phospholipases,
which hydrolyze phospholipid, and proteinases, which hydrolyze
peptide bonds.20 Although the role of these enzymes was not
clariﬁed, some elements from A. terreus might cause myocardial
damage.We should consider the possibility that A. terreus infection,
not disseminated infection, might result in myocardial damage to
DCM.
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